Literature DB >> 35754290

Central and Peripheral Inflammation: Connecting the Immune Responses of Parkinson's Disease.

Gregory P Williams1,2, Aubrey M Schonhoff2,3, Alessandro Sette1,2,4, Cecilia S Lindestam Arlehamn1,2.   

Abstract

Inflammation has increasingly become a focus of study in regards to Parkinson's disease (PD). Moreover, both central and peripheral sources of inflammation have been implicated in the pathogenesis of PD. Central inflammation consisting of activated microglia, astroglia, and T cell responses within the PD central nervous system; and peripheral inflammation referring to activated innate cells and T cell signaling in the enteric nervous system, gastrointestinal tract, and blood. This review will highlight important work that further implicates central and peripheral inflammation in playing a role in PD. We also discuss how these two distant inflammations appear related and how that may be mediated by autoantigenic responses to α-syn.

Entities:  

Keywords:  Neuroimmunology; Parkinson’s disease; T cells; central inflammation; neuroinflammation; peripheral inflammation

Mesh:

Substances:

Year:  2022        PMID: 35754290      PMCID: PMC9535591          DOI: 10.3233/JPD-223241

Source DB:  PubMed          Journal:  J Parkinsons Dis        ISSN: 1877-7171            Impact factor:   5.520


  57 in total

1.  Staging of brain pathology related to sporadic Parkinson's disease.

Authors:  Heiko Braak; Kelly Del Tredici; Udo Rüb; Rob A I de Vos; Ernst N H Jansen Steur; Eva Braak
Journal:  Neurobiol Aging       Date:  2003 Mar-Apr       Impact factor: 4.673

2.  TREM2 overexpression attenuates neuroinflammation and protects dopaminergic neurons in experimental models of Parkinson's disease.

Authors:  Manru Ren; Ying Guo; Xinbing Wei; Shaoqi Yan; Yue Qin; Xiumei Zhang; Fan Jiang; Haiyan Lou
Journal:  Exp Neurol       Date:  2018-02-03       Impact factor: 5.330

Review 3.  Cell Biology and Pathophysiology of α-Synuclein.

Authors:  Jacqueline Burré; Manu Sharma; Thomas C Südhof
Journal:  Cold Spring Harb Perspect Med       Date:  2018-03-01       Impact factor: 6.915

Review 4.  Cognitive decline in Parkinson disease.

Authors:  Dag Aarsland; Byron Creese; Marios Politis; K Ray Chaudhuri; Dominic H Ffytche; Daniel Weintraub; Clive Ballard
Journal:  Nat Rev Neurol       Date:  2017-03-03       Impact factor: 42.937

5.  Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease.

Authors:  Timothy R Sampson; Justine W Debelius; Taren Thron; Stefan Janssen; Gauri G Shastri; Zehra Esra Ilhan; Collin Challis; Catherine E Schretter; Sandra Rocha; Viviana Gradinaru; Marie-Francoise Chesselet; Ali Keshavarzian; Kathleen M Shannon; Rosa Krajmalnik-Brown; Pernilla Wittung-Stafshede; Rob Knight; Sarkis K Mazmanian
Journal:  Cell       Date:  2016-12-01       Impact factor: 41.582

6.  Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson's Disease.

Authors:  Sangjune Kim; Seung-Hwan Kwon; Tae-In Kam; Nikhil Panicker; Senthilkumar S Karuppagounder; Saebom Lee; Jun Hee Lee; Wonjoong Richard Kim; Minjee Kook; Catherine A Foss; Chentian Shen; Hojae Lee; Subhash Kulkarni; Pankaj J Pasricha; Gabsang Lee; Martin G Pomper; Valina L Dawson; Ted M Dawson; Han Seok Ko
Journal:  Neuron       Date:  2019-06-26       Impact factor: 17.173

7.  Neurotoxic reactive astrocytes induce cell death via saturated lipids.

Authors:  Maya K Weigel; Priya Prakash; Kevin A Guttenplan; Prageeth R Wijewardhane; Philip Hasel; Uriel Rufen-Blanchette; Alexandra E Münch; Jacob A Blum; Jonathan Fine; Mikaela C Neal; Kimberley D Bruce; Aaron D Gitler; Gaurav Chopra; Shane A Liddelow; Ben A Barres
Journal:  Nature       Date:  2021-10-06       Impact factor: 49.962

8.  Clinical and biochemical differences in patients having Parkinson disease with vs without GBA mutations.

Authors:  Lama M Chahine; Judy Qiang; Emily Ashbridge; James Minger; Dora Yearout; Stacy Horn; Amy Colcher; Howard I Hurtig; Virginia M-Y Lee; Vivianna M Van Deerlin; James B Leverenz; Andrew D Siderowf; John Q Trojanowski; Cyrus P Zabetian; Alice Chen-Plotkin
Journal:  JAMA Neurol       Date:  2013-07       Impact factor: 18.302

Review 9.  A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease.

Authors:  Francesco Panza; Bruno P Imbimbo; Madia Lozupone; Giancarlo Logroscino
Journal:  Nat Rev Neurol       Date:  2019-02       Impact factor: 42.937

10.  TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease.

Authors:  Sruti Rayaprolu; Bianca Mullen; Matt Baker; Timothy Lynch; Elizabeth Finger; William W Seeley; Kimmo J Hatanpaa; Catherine Lomen-Hoerth; Andrew Kertesz; Eileen H Bigio; Carol Lippa; Keith A Josephs; David S Knopman; Charles L White; Richard Caselli; Ian R Mackenzie; Bruce L Miller; Magdalena Boczarska-Jedynak; Grzegorz Opala; Anna Krygowska-Wajs; Maria Barcikowska; Steven G Younkin; Ronald C Petersen; Nilüfer Ertekin-Taner; Ryan J Uitti; James F Meschia; Kevin B Boylan; Bradley F Boeve; Neill R Graff-Radford; Zbigniew K Wszolek; Dennis W Dickson; Rosa Rademakers; Owen A Ross
Journal:  Mol Neurodegener       Date:  2013-06-21       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.